To explore the regulatory effects of B7-H3 on EGFR-TKIs treatment of lung adenocarcinoma harboring activated EGFR mutations, we administrated gefitinib to H3255 KO/mock and HCC827 KO/mock cell culture and monitored the ratio of apoptotic cells. This evidence concerns the gene EGFR and lung adenocarcinoma.